ESG

The 6th-gen Toyota RAV4 ditches gas engines, betting its all-hybrid lineup and new tech can keep it on top of the hyper-competitive small SUV market.

A historic $48M grant from Ballmer Group will enable Cal State LA to train over 1,000 new counselors, tackling LA's dire youth mental health crisis.

A renewed partnership between the Air Force Research Lab and USRA aims to cultivate the next generation of scientists for critical national security missions.

Newsweek names Bloom Energy a top trustworthy company. We explore how 25 years of reliability, investor confidence, and market demand are shaping its future.

Vitaquest's new CEO, Tim Condron, brings deep regulatory and operational expertise, signaling a strategic shift in a rapidly evolving supplement market.

Fintech firm Pagaya's latest AAA-rated deal attracts new investors, signaling strong confidence in its AI-driven lending model despite economic headwinds.

Decoy Therapeutics touts a revolutionary AI platform for multi-virus drugs, but faces financial hurdles. An upcoming investor event could define its future.

A major Canadian carrier is deploying Orange EV electric trucks, signaling a pivotal shift towards sustainable and cost-effective logistics, even in harsh climates.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

Hundreds of thousands of U.S.-born children live in exile after parental deportation. A new initiative aims to restore their rights and build a path home.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

With record revenue and A-list fans, British MedTech firm LYMA is doubling down on the US market, blending clinical data with celebrity appeal.

The ASEAN+3 region projects 4.0% growth but faces a severe energy shock. A new report reveals how a structural shift toward internal demand may be its shield.

A new service brings quiet, eco-friendly robotic lawnmowers to Toronto and Hamilton, promising to save homeowners time, money, and weekend headaches.

FDA clears Allevion's Vantage™, a disposable kit with integrated visualization that targets bone growth, aiming to transform spinal decompression.

The final phase of the Tour & Taxis transformation begins, promising a sustainable district with 700+ homes, affordable housing, and geothermal energy.

President Trump's 100% tariff on imported drugs aims to secure the US supply chain, but the policy's success may hinge on unproven and unverified players.